A detailed history of Engineers Gate Manager LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Engineers Gate Manager LP holds 20,072 shares of DVAX stock, worth $257,724. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,072
Previous 36,103 44.4%
Holding current value
$257,724
Previous $405,000 44.94%
% of portfolio
0.0%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.05 - $11.61 $161,111 - $186,119
-16,031 Reduced 44.4%
20,072 $223,000
Q2 2024

Aug 14, 2024

BUY
$10.73 - $12.58 $42,147 - $49,414
3,928 Added 12.21%
36,103 $405,000
Q1 2024

May 15, 2024

SELL
$11.7 - $14.98 $88,124 - $112,829
-7,532 Reduced 18.97%
32,175 $399,000
Q4 2023

Feb 14, 2024

BUY
$13.09 - $14.98 $519,764 - $594,810
39,707 New
39,707 $555,000
Q2 2023

Aug 14, 2023

BUY
$9.85 - $13.17 $110,566 - $147,833
11,225 New
11,225 $145,000
Q4 2022

Feb 14, 2023

BUY
$10.27 - $13.29 $327,684 - $424,044
31,907 Added 79.42%
72,084 $766,000
Q3 2022

Nov 14, 2022

BUY
$9.93 - $17.44 $398,957 - $700,686
40,177 New
40,177 $419,000
Q2 2022

Aug 15, 2022

SELL
$7.45 - $12.83 $100,217 - $172,589
-13,452 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$9.75 - $14.44 $551,411 - $816,654
-56,555 Reduced 80.78%
13,452 $146,000
Q4 2021

Feb 14, 2022

BUY
$13.17 - $20.94 $921,992 - $1.47 Million
70,007 New
70,007 $985,000
Q3 2021

Nov 15, 2021

SELL
$9.16 - $19.83 $419,546 - $908,253
-45,802 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$7.25 - $10.99 $60,885 - $92,294
-8,398 Reduced 15.49%
45,802 $451,000
Q1 2021

May 17, 2021

BUY
$4.57 - $11.18 $148,982 - $364,468
32,600 Added 150.93%
54,200 $533,000
Q4 2020

Feb 16, 2021

BUY
$3.73 - $5.6 $8,952 - $13,440
2,400 Added 12.5%
21,600 $96,000
Q3 2020

Nov 16, 2020

BUY
$4.32 - $11.7 $36,720 - $99,450
8,500 Added 79.44%
19,200 $83,000
Q2 2020

Aug 17, 2020

BUY
$2.94 - $9.1 $31,458 - $97,370
10,700 New
10,700 $95,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.62B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.